
Linamide10 mg
Beacon Pharmaceuticals PLC
Lenalidomide is an oral immunomodulatory antineoplastic agent (a thalidomide analog) used in the treatment of certain blood cancers.
Lenalidomide is an oral immunomodulatory antineoplastic agent (a thalidomide analog) used in the treatment of certain blood cancers. Its established, FDA-approved indications include:
Lenalidomide must only be prescribed and monitored by a physician experienced in the use of antineoplastic/immunomodulatory therapy, under a controlled distribution and risk-management program.
Lenalidomide dosing is individualized by indication and is administered orally once daily, preferably at the same time each day, with or without food. Capsules should be swallowed whole with water and must not be opened, broken, or chewed; women who are pregnant should avoid handling the capsules.
| Indication | Typical Adult Dose |
|---|---|
| Multiple myeloma (with dexamethasone) | 25 mg once daily on Days 1-21 of each repeated 28-day cycle |
| Multiple myeloma (post-transplant maintenance) | 10 mg once daily continuously (Days 1-28 of each 28-day cycle); may be increased to 15 mg daily after 3 cycles if tolerated |
| Myelodysplastic syndrome with del5q | 10 mg once daily, continued or adjusted based on blood counts and response |
| Mantle cell lymphoma | 25 mg once daily on Days 1-21 of each 28-day cycle |
| Follicular/marginal zone lymphoma (with rituximab) | 20 mg once daily on Days 1-21 of each 28-day cycle, for up to 12 cycles |
| Renal Function (CrCl) | MM/MCL Dose | FL/MZL Dose | MDS/Post-HSCT Dose |
|---|---|---|---|
| 30-60 mL/min | 10 mg daily | 10 mg daily | 5 mg daily |
| <30 mL/min (not on dialysis) | 15 mg every other day | 5 mg daily | 2.5 mg daily |
| <30 mL/min (on dialysis) | 5 mg daily (after dialysis) | 5 mg daily (after dialysis) | 2.5 mg daily (after dialysis) |
Dose may also require modification for hematologic toxicity (neutropenia, thrombocytopenia) as directed by the treating physician. Do not alter the dose or stop Lenalidomide without medical advice.
Common side effects of Lenalidomide vary somewhat by indication but commonly include:
Serious but less common effects include severe blood clots (deep vein thrombosis, pulmonary embolism), heart attack or stroke, severe skin reactions, tumor lysis syndrome, and second primary malignancies. Report any unusual bruising/bleeding, leg swelling, chest pain, shortness of breath, or severe rash to a physician immediately.
Lenalidomide is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.